News

FDA-approved Bionect is indicated for the management of irritation of the skin as well as first and second degree burns, and is currently being promoted and sold by

ADC Therapeutics was formed with an initial budget of $50m and 10 ADC development programs. The company’s plan will be to seek development and marketing partners after Phase

The $322,000 grant is a supplemental award to expand on promising initial research conducted by ACADIA under an earlier grant from MJFF. The new grant is intended to

Under the agreement, the companies will commercialise Ruconest (recombinant human C1 inhibitor) for the treatment of acute attacks of Hereditary Angioedema (HAE) in the Republic of Korea. Ruconest

As per the agreement Pharmaplan has exclusive rights to market and sell Nalox /Emtrix in South Africa. Moberg is responsible for production and supply of the product. Nalox

The company may set up a manufacturing facility in Japan as a part of the joint venture agreement. The new JV will have 51% stake owned by Fujifilm

The FDA did not complete the review of Levadex’s new drug application, because of chemistry, manufacturing and controls issues observed during an inspection of the third-party manufacturer, the

Both the partners signed a new strategic agreement to collaborate in the area of biomedical sciences over the next three years. BTC was established by Bayer HealthCare and

The solution leverages LabConnect’s software, SampleREACH, which provides web-based sample tracking including collection, shipment, and receipt at any laboratory or location worldwide. The software enables instant accessioning and